Please login to the form below

Not currently logged in
Email:
Password:

Internis appoints Sandoz's Paul Tredwell

He joins the UK bone disorder-focused start-up as chief operating officer

Internis Paul TredwellInternis has poached Sandoz's former head of biopharmaceuticals Paul Tredwell to serve as its chief operating officer.  

Tredwell joins the UK bone disorder-focused start-up after serving at Sandoz for four years, during which time he set up a new division in the UK and was directly responsible for managing the sales, marketing and medical functions.  

Prior to his time with the firm, which operates as Novartis' generics division, Tredwell spent eight years with Shire in senior sales and marketing positions. These included leading the UK specialist sales teams as well as its commercial and NHS teams.  

Paul began his career in the pharmaceutical industry with Galen 16 years ago where he served as area sales manager.  

In his new role Tredwell will be tasked with driving sales of Internis' calcium products FultiumD3 and Accrete D3, as well as a number of new products the firm plans to introduce early next year.  

He will report to Internis' joint CEO Alan Walker who said: "We are delighted to have Paul Tredwell join our team. Paul is a recognised global leader in his field.  

“His skills, knowledge and extensive experience in the industry, as well as his ability to deliver results, make him the ideal candidate to lead Internis into the next exciting phase of its development."

27th August 2013

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Pegasus

Pegasus inspires healthy decisions through creative, inspirational and integrated communications. Working with ambitious clients, we deliver big ideas and far-reaching...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics